Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-01-26 @ 3:59 AM
Study NCT ID:
NCT06530550
Status:
RECRUITING
Last Update Posted:
2025-08-12
First Post:
2024-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-10
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-10
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-28
First Submit QC Date:
None
Study First Post Date:
2024-07-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-11
Last Update Post Date:
2025-08-12
Last Update Post Date Type:
ACTUAL